Santhera Pharmaceuticals Holding AG/€SANN
1D1W1MYTD1Y5YMAX
Capital at risk
About Santhera Pharmaceuticals Holding AG
Santhera Pharmaceuticals Holding AG is a Swiss pharmaceutical company focused on the development and commercialization of innovative treatments for rare and debilitating diseases. The company's key areas of expertise include neuromuscular and pulmonary disorders. Santhera's product pipeline features several investigational drugs targeting conditions such as Duchenne muscular dystrophy and cystic fibrosis. Headquartered in Pratteln, Switzerland, the company leverages its scientific expertise and industry partnerships to advance its therapeutic offerings. Santhera's strategic focus on niche markets allows it to address unmet medical needs, providing potential opportunities for growth within specialized segments of the healthcare industry.
- Ticker
- €SANN
- Sector
- Health
- Primary listing
- XGAT
- Employees
- 94
- Headquarters
- Pratteln, Switzerland
- Website
- www.santhera.com
SANN Metrics
BasicAdvanced
€252M
-
-€4.01
-0.34
-
Price and volume
Market cap
€252M
Beta
-0.34
52-week high
€19.40
52-week low
€10.20
Average daily volume
85K
Financial strength
Current ratio
1.291
Quick ratio
0.78
Long term debt to equity
-2.886
Total debt to equity
-4.143
Interest coverage (TTM)
-3.25%
Profitability
EBITDA (TTM)
-33.831
Gross margin (TTM)
19.66%
Net profit margin (TTM)
-63.79%
Operating margin (TTM)
-48.73%
Effective tax rate (TTM)
-0.38%
Revenue per employee (TTM)
€868,760
Management effectiveness
Return on assets (TTM)
-15.64%
Return on equity (TTM)
-620.02%
Valuation
Price to revenue (TTM)
2.629
Price to book
-17.64
Price to tangible book (TTM)
-2.75
Price to free cash flow (TTM)
-5.829
Free cash flow yield (TTM)
-17.16%
Free cash flow per share (TTM)
-2.834
Growth
Revenue change (TTM)
97.32%
Earnings per share change (TTM)
2.44%
3-year revenue growth (CAGR)
117.78%
10-year revenue growth (CAGR)
33.41%
3-year earnings per share growth (CAGR)
-31.32%
10-year earnings per share growth (CAGR)
-9.97%
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.